1. Home
  2. BBWI vs HALO Comparison

BBWI vs HALO Comparison

Compare BBWI & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBWI
  • HALO
  • Stock Information
  • Founded
  • BBWI 1963
  • HALO 1998
  • Country
  • BBWI United States
  • HALO United States
  • Employees
  • BBWI N/A
  • HALO N/A
  • Industry
  • BBWI Clothing/Shoe/Accessory Stores
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BBWI Consumer Discretionary
  • HALO Health Care
  • Exchange
  • BBWI Nasdaq
  • HALO Nasdaq
  • Market Cap
  • BBWI 6.7B
  • HALO 6.4B
  • IPO Year
  • BBWI N/A
  • HALO N/A
  • Fundamental
  • Price
  • BBWI $31.54
  • HALO $45.65
  • Analyst Decision
  • BBWI Buy
  • HALO Buy
  • Analyst Count
  • BBWI 17
  • HALO 9
  • Target Price
  • BBWI $41.71
  • HALO $61.11
  • AVG Volume (30 Days)
  • BBWI 5.3M
  • HALO 1.7M
  • Earning Date
  • BBWI 11-25-2024
  • HALO 10-31-2024
  • Dividend Yield
  • BBWI 2.54%
  • HALO N/A
  • EPS Growth
  • BBWI 35.32
  • HALO 61.71
  • EPS
  • BBWI 4.14
  • HALO 3.02
  • Revenue
  • BBWI $7,384,000,000.00
  • HALO $947,355,000.00
  • Revenue This Year
  • BBWI N/A
  • HALO $23.36
  • Revenue Next Year
  • BBWI $2.79
  • HALO $15.15
  • P/E Ratio
  • BBWI $7.61
  • HALO $15.10
  • Revenue Growth
  • BBWI N/A
  • HALO 21.35
  • 52 Week Low
  • BBWI $26.21
  • HALO $33.15
  • 52 Week High
  • BBWI $52.99
  • HALO $65.53
  • Technical
  • Relative Strength Index (RSI)
  • BBWI 55.05
  • HALO 30.20
  • Support Level
  • BBWI $29.72
  • HALO $50.01
  • Resistance Level
  • BBWI $32.10
  • HALO $62.13
  • Average True Range (ATR)
  • BBWI 1.07
  • HALO 2.60
  • MACD
  • BBWI 0.16
  • HALO -0.50
  • Stochastic Oscillator
  • BBWI 80.68
  • HALO 0.15

About BBWI Bath & Body Works Inc.

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2023. For fiscal 2023, 74% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2022 levels, as consumer shopping patterns remained to normal. Future growth is expected from store reformatting, digital and international channels, as well as adjacent category expansions like hair and laundry.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: